MP, G., SM, W., JM, S., CL, O., KE, L., LR, B., & JL, V. (2015). Oral Targeted Therapies and Central Nervous System (CNS) Metastases. CNS drugs, 29(11), 935. https://doi.org/10.1007/s40263-015-0283-6
Chicago Style (17th ed.) CitationMP, Gabay, Wirth SM, Stachnik JM, Overley CL, Long KE, Bressler LR, and Villano JL. "Oral Targeted Therapies and Central Nervous System (CNS) Metastases." CNS Drugs 29, no. 11 (2015): 935. https://doi.org/10.1007/s40263-015-0283-6.
MLA (9th ed.) CitationMP, Gabay, et al. "Oral Targeted Therapies and Central Nervous System (CNS) Metastases." CNS Drugs, vol. 29, no. 11, 2015, p. 935, https://doi.org/10.1007/s40263-015-0283-6.
Warning: These citations may not always be 100% accurate.